Published in
Elsevier, Annals of Oncology, 1(35), p. 66-76, 2024
DOI: 10.1016/j.annonc.2023.10.004
Links
Tools
SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer
Journal article published in 2024 by
H. Borghaei 
,
F. de Marinis,
D. Dumoulin ,
C. Reynolds,
W. S. M. E. Theelen ,
I. Percent,
V. Gutierrez Calderon,
M. L. Johnson,
A. Madroszyk-Flandin ,
E. B. Garon ,
K. He,
D. Planchard,
M. Reck,
S. Popat ,
R. S. Herbst
and other authors.
,
F. de Marinis,
D. Dumoulin ,
C. Reynolds,
W. S. M. E. Theelen ,
I. Percent,
V. Gutierrez Calderon,
M. L. Johnson,
A. Madroszyk-Flandin ,
E. B. Garon ,
K. He,
D. Planchard,
M. Reck,
S. Popat ,
R. S. Herbst
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 